93 related articles for article (PubMed ID: 29180609)
1. Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe.
Rachamala HK; Madamsetty VS; Angom RS; Nakka NM; Dutta SK; Wang E; Mukhopadhyay D; Pal K
J Exp Clin Cancer Res; 2024 Jun; 43(1):159. PubMed ID: 38840237
[TBL] [Abstract][Full Text] [Related]
2. Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
Katiyar SK
Molecules; 2016 Nov; 21(12):. PubMed ID: 27886147
[TBL] [Abstract][Full Text] [Related]
3. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
[TBL] [Abstract][Full Text] [Related]
4. Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth.
Sheu ML; Liu SH; Lan KH
PLoS One; 2007 Oct; 2(10):e1096. PubMed ID: 17971859
[TBL] [Abstract][Full Text] [Related]
5. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
Saba NF; Wang X; Müller S; Tighiouart M; Cho K; Nie S; Chen Z; Shin DM
Head Neck; 2009 Apr; 31(4):475-81. PubMed ID: 19072997
[TBL] [Abstract][Full Text] [Related]
6. Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe.
Rachamala HK; Madamsetty VS; Angom RS; Nakka NM; Kumar Dutta S; Wang E; Mukhopadhyay D; Pal K
Res Sq; 2023 Dec; ():. PubMed ID: 38196607
[TBL] [Abstract][Full Text] [Related]
7. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.
Hamstra DA; Lee KC; Moffat BA; Chenevert TL; Rehemtulla A; Ross BD
Transl Oncol; 2008 Dec; 1(4):187-94. PubMed ID: 19043529
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective inhibition of STAT3 tyrosine 705 phosphorylation.
Fei Y; Zhang X; Wang X; Sun Y; He J; Liu X; Song Z; Li L; Qiu L; Qian Z; Zhou S; Liu X; Zhang H; Wang X
J Nat Med; 2024 Mar; 78(2):285-295. PubMed ID: 38082192
[TBL] [Abstract][Full Text] [Related]
9. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review.
Ansari MJ; Bokov D; Markov A; Jalil AT; Shalaby MN; Suksatan W; Chupradit S; Al-Ghamdi HS; Shomali N; Zamani A; Mohammadi A; Dadashpour M
Cell Commun Signal; 2022 Apr; 20(1):49. PubMed ID: 35392964
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications.
Wium M; Ajayi-Smith AF; Paccez JD; Zerbini LF
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806258
[TBL] [Abstract][Full Text] [Related]
11. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions.
Güllülü Ö; Hehlgans S; Rödel C; Fokas E; Rödel F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557398
[TBL] [Abstract][Full Text] [Related]
12. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
13. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
[TBL] [Abstract][Full Text] [Related]
14. Honokiol: A Review of Its Anticancer Potential and Mechanisms.
Ong CP; Lee WL; Tang YQ; Yap WH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877856
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of survivin and X-linked inhibitor of apoptosis protein suppresses the growth and promotes the apoptosis of gastric cancer HGC-27 cells.
Li Y; Gao W; Ma Y; Zhu G; Chen F; Qu H
Oncol Lett; 2018 Sep; 16(3):3489-3498. PubMed ID: 30127953
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
[TBL] [Abstract][Full Text] [Related]
17. Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
Wang X; Beitler JJ; Huang W; Chen G; Qian G; Magliocca K; Patel MR; Chen AY; Zhang J; Nannapaneni S; Kim S; Chen Z; Deng X; Saba NF; Chen ZG; Arbiser JL; Shin DM
Clin Cancer Res; 2018 Feb; 24(4):858-869. PubMed ID: 29180609
[No Abstract] [Full Text] [Related]
18. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
19. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
